GIMAP2 and lung carcinoma: The survival analysis of the GIMAP family was performed, and the results showed that high levels of GIMAP1, GIMAP2, GIMAP4, GIMAP5, GIMAP, GIMAP7 and GIMAP8 mRNA expression levels were associated with better overall survival of patients with lung cancer (Figure 2A).